Insider · CIK 0000902418

ABELES JOHN H

Reports to the SEC for 7 companies · LAKE FOREST, CA

sec.gov

Transactions

Companies

Filings

CIK

0000902418

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-10-11	Medite Cancer Diagnostics, Inc.P Purchase	Director	PPurchase	+267K sh	$0.07	+$20K	1,566,852
2018-08-13	Medite Cancer Diagnostics, Inc.J Other	Director	JOther	+40K sh	—	—	1,300,185
2018-07-03	Medite Cancer Diagnostics, Inc.P Purchase	Director	PPurchase	+400K sh	$0.07	+$30K	2,608,381
2015-11-13	Neurotrope, Inc.Series B WarrantP Purchase	10% Owner	PPurchase	+208K sh	—	—	208,334
2015-11-13	Neurotrope, Inc.Series C WarrantP Purchase	10% Owner	PPurchase	+208K sh	—	—	208,334
2015-11-13	Neurotrope, Inc.Series D WarrantP Purchase	10% Owner	PPurchase	+208K sh	—	—	208,334
2015-11-13	Neurotrope, Inc.Series E WarrantA Award	10% Owner	AAward	+167K sh	—	—	166,667
2015-11-13	Neurotrope, Inc.Series D WarrantA Award	10% Owner	AAward	+167K sh	—	—	166,667
2015-11-13	Neurotrope, Inc.Series C WarrantA Award	10% Owner	AAward	+167K sh	—	—	166,667
2015-11-13	Neurotrope, Inc.Series B WarrantA Award	10% Owner	AAward	+167K sh	—	—	166,667
2015-11-13	Neurotrope, Inc.Series A WarrantA Award	10% Owner	AAward	+167K sh	—	—	166,667
2015-11-13	Neurotrope, Inc.Series E WarrantP Purchase	10% Owner	PPurchase	+208K sh	—	—	208,334
2015-11-13	Neurotrope, Inc.Series B Preferred StockA Award	10% Owner	AAward	+1,666.67 sh	—	—	166,667
2015-11-13	Neurotrope, Inc.Series B Preferred StockP Purchase	10% Owner	PPurchase	+2,083.34 sh	—	—	208,334
2015-11-13	Neurotrope, Inc.Series A WarrantP Purchase	10% Owner	PPurchase	+208K sh	—	—	208,334
2012-01-03	CombiMatrix CorpStock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-04-07	CombiMatrix CorpCommon Stock Warrants (right to buy)A Award	Director	AAward	+3,875 sh	—	—	3,875
2011-04-07	CombiMatrix CorpA Award	Director	AAward	+9,119 sh	—	—	9,119
2011-01-03	CombiMatrix CorpStock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2010-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2010-01-04	CombiMatrix CorpCommon Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2009-12-17	DUSA PHARMACEUTICALS INCP Purchase	Director	PPurchase	+20K sh	$1.30	+$26K	77,000
2009-12-16	DUSA PHARMACEUTICALS INCP Purchase	Director	PPurchase	+20K sh	$1.26	+$25.1K	57,000
2009-11-24	I FLOW CORP /DE/J Other	Director	JOther	−5,000 sh	$12.65	−$63.3K	0
2009-11-18	I FLOW CORP /DE/U Disposition from Tender	Director	UDisposition from Tender	−333K sh	$12.65	−$4.21M	5,000
2009-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2009-03-13	DUSA PHARMACEUTICALS INCA Award	Director	AAward	+7,500 sh	—	—	12,500
2009-01-02	CombiMatrix CorpDirector Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2009-01-02	I FLOW CORP /DE/A Award	Director	AAward	+5,000 sh	—	—	337,500
2008-01-02	CombiMatrix CorpDirector Stock Option (Right to Buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2007-08-15	CombiMatrix CorpDirector Stock Option (Right to Buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2007-08-15	CombiMatrix CorpDirector Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2007-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2006-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2006-01-02	I FLOW CORP /DE/A Award	Director	AAward	+5,000 sh	—	—	340,000
2005-07-22	ORYX TECHNOLOGY CORPWarrant to Purchase Common StockJ Other	Director	JOther	−2,278 sh	—	—	0
2005-07-22	ORYX TECHNOLOGY CORPP Purchase	Director	PPurchase	+7,278 sh	$1.50	+$10.9K	83,220
2005-07-22	ORYX TECHNOLOGY CORPWarrant to Purchase Common StockJ Other	Director	JOther	−5,000 sh	—	—	0
2005-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2005-01-20	DUSA PHARMACEUTICALS INCS Sale	Director	SSale	−10K sh	$15.00	−$150K	10,000
2005-01-19	DUSA PHARMACEUTICALS INCNon Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2005-01-19	DUSA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$2.51	+$25.1K	10,000
2005-01-19	DUSA PHARMACEUTICALS INCNon Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2005-01-19	DUSA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$6.94	+$69.4K	20,000
2005-01-03	I FLOW CORP /DE/Director Stock OptionG Gift	Director	GGift	+10K sh	—	—	20,000
2004-12-01	I FLOW CORP /DE/S Sale	Director	SSale	−10K sh	$20.42	−$204K	350,000
2004-01-13	I FLOW CORP /DE/Director OptionsM Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	10,000
2004-01-13	I FLOW CORP /DE/M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$1.66	+$4,150	382,500
2004-01-02	I FLOW CORP /DE/Director OptionsA Award	Director	AAward	+10K sh	—	—	12,500
2003-12-16	ReAble Therapeutics, Inc.S Sale	Director	SSale	−53.2K sh	$6.25	−$333K	341,709

Recent filings

Accepted (ET)
Oct 234
ABELES JOHN H0001415889-18-001538
SEC(opens sec.gov)
Jul 104
ABELES JOHN H0001415889-18-001103
SEC(opens sec.gov)
Nov 174
Neurotrope, Inc.0001144204-15-066402
SEC(opens sec.gov)
Jan 54
ABELES JOHN H0001179110-12-000424
SEC(opens sec.gov)
Apr 114
ABELES JOHN H0001179110-11-006343
SEC(opens sec.gov)
Jan 74
ABELES JOHN H0001179110-11-000774
SEC(opens sec.gov)
Jul 14
ABELES JOHN H0001209191-10-036341
SEC(opens sec.gov)

Companies

Address

20202 WINDROW DRIVE

LAKE FOREST, CA, 92630